Literature DB >> 12114009

Risk factors for Aujeszky's-disease seropositivity of swine herds of a region of northern Italy.

M Tamba1, R Calabrese, E Finelli, P Cordioli.   

Abstract

Vaccination programs to control Aujeszky's-disease virus (ADV) using gE-deleted vaccines are being considered in several European countries. Knowledge of factors influencing ADV-seropositivity for vaccinated herds might contribute to the success of these programs. A multivariable analysis of ADV-seropositivity in 1248 swine herds (332 farrow-to-finish, 260 farrow-to-feeder and 656 finishing herds) in the Emilia-Romagna region of Italy revealed that (1) high pig density (number of pigs in a 6-km radius), (2) gilt purchasing, and (3) increased number of fattening pigs were risk factors for farrow-to-finish herds. In farrow-to-feeder herds, ADV-seropositivity was related to (1) increased number of breeders, (2) heavy-gilt purchasing, and (3) increased pig density. In finishing herds, (1) increased herd size was related to ADV-seropositivity, whereas (2) periodic rearing suspension was protective.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114009     DOI: 10.1016/s0167-5877(02)00028-4

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  3 in total

1.  Seroprevalence and associated risk factors of pseudorabies in Shandong province of China.

Authors:  Dongfang Hu; Lin Lv; Zhendong Zhang; Yihong Xiao; Sidang Liu
Journal:  J Vet Sci       Date:  2016-09-30       Impact factor: 1.672

2.  Diagnosis and gI antibody dynamics of pseudorabies virus in an intensive pig farm in Hei Longjiang Province.

Authors:  Jintao Wang; Huansheng Han; Wanning Liu; Shinian Li; Donghua Guo
Journal:  J Vet Sci       Date:  2021-03       Impact factor: 1.672

3.  Aujeszky's disease and the effects of infection on Japanese swine herd productivity: a cross-sectional study.

Authors:  Itsuro Yamane; Sayoko Ishizeki; Hisanori Yamazaki
Journal:  J Vet Med Sci       Date:  2015-01-07       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.